Neurodawn Pharmaceutical Co., Ltd.

Chine

 
Quantité totale PI 19
Rang # Quantité totale PI 78 497
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 169

Brevets

Marques

8 0
5 0
6 0
0
 
Dernier brevet 2025 - Use of a class of 1,4-dihydro-na...
Premier brevet 2012 - N-benzylaniline derivative and u...

Derniers inventions, produits et services

2022 Invention Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors. The present inve...
Invention Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors. The present inven...
Invention Application of composition containing edaravone and dexborneol in improving or treating cognitive...
Invention Pharmaceutical composition and use thereof. The present invention relates to a composition of (S...
Invention Pharmaceutical composition and use thereof. The present invention relates to a composition ...
Invention Pharmaceutical composition and use thereof. The present invention relates to a composition of (S)...
Invention Application of riluzole- and borneol-containing composition in preparation of medication for trea...
Invention Use of composition containing cilostazol in cerebrovascular diseases. Disclosed is the use of a ...
Invention Use of composition containing vinpocetine in cerebrovascular diseases. Disclosed is the use of a ...
Invention Application of cilostazol-containing composition in preparing drug for treating cerebrovascular d...
2017 Invention Sublingual pharmaceutical compositions of edaravone and (+)-2-borneol. A sublingual tablet pharma...
Invention Sublingual pharmaceutical composition of edaravone and (+)-2-borneol. A sublingual tablet pharmac...
2012 Invention 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof. Disclosed ar...
Invention N-benzylaniline derivative and uses thereof. A N-benzylaniline derivative and uses thereof. The d...